Nature Reviews Clinical Oncology Impact Factor, Indexing, Ranking

Nature Reviews Clinical Oncology Impact Factor, Indexing, Ranking

Nature Reviews Clinical Oncology (NRCO) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by Nature Publishing. The Print-ISSN to Nature Reviews Clinical Oncology is 1759-4774 and its abbreviation is Nat Rev Clin Oncol.


Nature Reviews Clinical Oncology Aim and Scope

Aims & Scope Nature Reviews' clinical content is written by internationally renowned clinical academics and researchers and targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any medical discipline.

In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals.

Subjects Covered

Chemotherapy Clinical pharmacology Diagnosis Epidemiology Experimental therapies Genetics Health services, economics and outcomes research Hematology Hormonal therapies Imaging Immunotherapy Medical oncology Palliative care Pathology Pediatric oncology Prevention Radiotherapy Screening Signal transduction Statistics Surgical oncology Targeted therapies


Nature Reviews Clinical Oncology Details


Journal title Nature Reviews Clinical Oncology (NRCO)
Abbreviation Nat Rev Clin Oncol
Print ISSN 1759-4774
Online ISSN 1759-4782
Publisher Name Nature Publishing
Editor-in-chief Diana Romero, BSc, PhD
Subject Category Medicine
Impact Factor 82.7
SJR 14.809
SNIP 8.319
Ranking 10
CiteScore 75.5
H-Index 198
Quartile Q1
Status 🟢 Active
Abstracting and Indexing
Impact Factor List 2024

Who we are? Clarification: Journals Insights - Your Open Access Ally
F T L W E